Results 1 - 20 of 138 in Laboratory Corporation of America Holdings
-
ARCA biopharma to Present at JMP Securities Healthcare Focus Conference
Michael Bristow , M.D., ARCA's chairman and chief science and medical officer, will present at the Third Annual JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 , at in New York City .
Comment?
-
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM)...
LYONs are convertible into Common Stock of LabCorp at the conversion rate of 13.4108 per $1,000 principal amount at maturity of the LYONs, subject to the terms of the LYONs and the Indenture, dated as of ...
Comment?
-
J. David Bavousett Joins LibLime as Implementation Specialist
October 1, 2008--LibLime, the leader in open-source solutions for libraries, announced today that J. David Bavousett has joined LibLime as Implementation Specialist.
Comment?
-
Kannapolis townhomes on hold, but housing on schedule around golf course; real estate VP out
Despite a delay in townhome construction and a change of leadership, Castle & Cooke officials say development at the N.C. Research Campus is going well.
Comment?
-
Stocks rallied at the close Thursday as government officials neared approval of a federal bailout plan.
Comment?
-
Bucindolol Significantly Reduces Hospitalization and Death in Heart...
Bucindolol, an investigational, pharmacologically unique beta-blocker and mild vasodilator, significantly reduces hospitalization and death among heart failure patients with very favorable genotypes, according ...
Comment?
-
FDA Accepts New Drug Application for Bucindolol, A...
ARCA biopharma, Inc. announced today that the U.S. Food and Drug Administration has accepted a New Drug Application for the company's lead product candidate, bucindolol, an investigational and pharmacologically ...
Comment?
-
American Journal Of Gastroenterology Publishes Study Of Advanced...
... in the detection of cancer. EXACT maintains an exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp) relating to the Company's intellectual property. EXACT Sciences' stool-based DNA technology is included in the ...
Comment?
-
American Journal of Gastroenterology Publishes Study of Advanced...
... in the detection of cancer. EXACT maintains an exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp ) relating to the Company ' s intellectual property. EXACT Sciences ' stool-based DNA technology is included in the ...
Comment?
-
Bucindolol Significantly Reduces Hospitalization and Death in Heart...
Bucindolol, an investigational, pharmacologically unique beta-blocker and mild vasodilator, significantly reduces hospitalization and death among heart failure patients with very favorable genotypes, according ...
Comment?
-
UBS Global Life Sciences Conference Opens in New York
The Tenth Annual UBS Global Life Sciences Conference begins today at the Grand Hyatt in New York City and continues through Thursday, September 25.
Comment?
-
Air show puts heart into love affair with flying
Matt Ryerson/The Hawk Eye Mark Dusek, 12, looks up in amazement as his dad, Jerry, both of Fruitland, takes a picture of the Aerostars performance during the 2008 Southeast Iowa Air Show Saturday at Sooutheast ...
Comment?
-
Labcorp Is Scheduled To Present At The UBS 2008 Global Life Sciences Conference
Laboratory Corporation of America Holdings today announced that David P. King, Chief Executive Officer and William B. Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the ...
Comment?
-
Baxter International lawsuit accuses rival of patent violations
Deerfield-based Baxter International Inc. and Laboratory Corp. of America Holdings sued Talecris Biotherapeutics Inc., accusing it in a U.S. court of violating patents related to genetic testing for viruses.
Comment?
-
LabCorp is Scheduled to Present at the Bank of America 38th Annual Investment Conference
Laboratory Corporation of America Holdings today announced that David P. King, Chief Executive Officer and William B. Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the ...
Comment?
-
LabCorp is Scheduled to Present at the Bank of America 38th Annual Investment Conference
Laboratory Corporation of America Holdings today announced that David P. King, Chief Executive Officer and William B. Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the ...
Comment?
-
An Analysis of the Cardiovascular Biomarkers Market: Providing a...
Research and Markets has announced the addition of the "Cardiovascular Biomarkers: Players, Products and Prospects " report to their offering.
Comment?
-
LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon...
Laboratory Corporation of America Holdings announced today that for the period of September 12, 2008 to March 11, 2009, its zero coupon subordinated Liquid Yield Option Notes due 2021 and Zero Coupon ...
Comment?
-
Plexigen, Inc. Announces the Appointment of Bill Haas as President and CEO
"Bill spent eighteen years at Laboratory Corporation of America, Inc., in many dynamic roles, most recently as their Executive Vice President, Esoteric Business.
Comment?
-
Denied permission to change into civilian clothes, convicted killer Brian Rooney refused to attend his appeals hearing Wednesday in Burlington.
Comment?
Laboratory Corporation of America Holdings Forum
Most Popular